Greenwood Capital Associates’s Pediatrix Medical MD Stock Holding History

Greenwood Capital Associates’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,090	Closed	-$314K	–	165
2015 Q3	$314K	Buy	4,090 +40	+1%	+$3.23K	0.11%	106
2015 Q2	$300K	Buy	4,050 +20	+0.5%	+$1.44K	0.09%	113
2015 Q1	$292K	Buy	4,030 +140	+4%	+$9.73K	0.08%	116
2014 Q4	$257K	Buy	3,890 +50	+1%	+$3.05K	0.07%	122
2014 Q3	$211K	Buy	3,840 +20	+0.5%	+$1.14K	0.06%	125
2014 Q2	$222K	Buy	+3,820	New	+$225K	0.07%	120

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Greenwood Capital Associates's MD Position: Q4 2015 in Review

Greenwood Capital Associates sold out of Pediatrix Medical (MD) in Q4 2015, closing a stake of 4,090 shares — an estimated $314K sold.

Greenwood Capital Associates first reported a position in MD in Q2 2014 and held it in 6 quarters. The position peaked at $314K in Q3 2015. 399 funds tracked by Wall St. Rank hold MD as of Q4 2015.

Greenwood Capital Associates reported no remaining Pediatrix Medical position as of Q4 2015 after selling out during the quarter.
Greenwood Capital Associates sold 4,090 Pediatrix Medical shares in Q4 2015, an estimated $314K.
Greenwood Capital Associates first reported a position in Pediatrix Medical in Q2 2014 and held it in 6 quarters.
Greenwood Capital Associates's Pediatrix Medical position peaked at $314K in Q3 2015.
399 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2015.

Based on Greenwood Capital Associates's 13F filing for Q4 2015, filed 10 Feb 2016.